Pharmacology

at-home medication, patient safety, medication reconciliation, discrepancy, adverse drug event, ADE, cardiovascular drugat-home medication, patient safety, medication reconciliation, discrepancy, adverse drug event, ADE, cardiovascular drug

at-home medication, patient safety, medication reconciliation, discrepancy, adverse drug event, ADE, cardiovascular drugat-home medication, patient safety, medication reconciliation, discrepancy, adverse drug event, ADE, cardiovascular drug

at-home medication, patient safety, medication reconciliation, discrepancy, adverse drug event, ADE, cardiovascular drugat-home medication, patient safety, medication reconciliation, discrepancy, adverse drug event, ADE, cardiovascular drug

proton pump inhibitors, PPI, heartburn, fracture, epidemiologic study, esomeprazole, dexlansoprazole, omeprazole, lansoprazole, FDAproton pump inhibitors, PPI, heartburn, fracture, epidemiologic study, esomeprazole, dexlansoprazole, omeprazole, lansoprazole, FDA

proton pump inhibitors, PPI, heartburn, fracture, epidemiologic study, esomeprazole, dexlansoprazole, omeprazole, lansoprazole, FDAproton pump inhibitors, PPI, heartburn, fracture, epidemiologic study, esomeprazole, dexlansoprazole, omeprazole, lansoprazole, FDA

proton pump inhibitors, PPI, heartburn, fracture, epidemiologic study, esomeprazole, dexlansoprazole, omeprazole, lansoprazole, FDAproton pump inhibitors, PPI, heartburn, fracture, epidemiologic study, esomeprazole, dexlansoprazole, omeprazole, lansoprazole, FDA

weight loss, orlistat, Alli, Xenical, liver damage, FDA, liver injury, Genentech, GlaxoSmithKlineweight loss, orlistat, Alli, Xenical, liver damage, FDA, liver injury, Genentech, GlaxoSmithKline

weight loss, orlistat, Alli, Xenical, liver damage, FDA, liver injury, Genentech, GlaxoSmithKlineweight loss, orlistat, Alli, Xenical, liver damage, FDA, liver injury, Genentech, GlaxoSmithKline

weight loss, orlistat, Alli, Xenical, liver damage, FDA, liver injury, Genentech, GlaxoSmithKlineweight loss, orlistat, Alli, Xenical, liver damage, FDA, liver injury, Genentech, GlaxoSmithKline

nonadherance, chronic ischemic heart disease, Beliefs about Medicines Questionnaire-Specific, BMQ-Specific, Medication Applied and Stustained Over Time, MAINTAIN, heart medication, adherancenonadherance, chronic ischemic heart disease, Beliefs about Medicines Questionnaire-Specific, BMQ-Specific, Medication Applied and Stustained Over Time, MAINTAIN, heart medication, adherance

nonadherance, chronic ischemic heart disease, Beliefs about Medicines Questionnaire-Specific, BMQ-Specific, Medication Applied and Stustained Over Time, MAINTAIN, heart medication, adherancenonadherance, chronic ischemic heart disease, Beliefs about Medicines Questionnaire-Specific, BMQ-Specific, Medication Applied and Stustained Over Time, MAINTAIN, heart medication, adherance

nonadherance, chronic ischemic heart disease, Beliefs about Medicines Questionnaire-Specific, BMQ-Specific, Medication Applied and Stustained Over Time, MAINTAIN, heart medication, adherancenonadherance, chronic ischemic heart disease, Beliefs about Medicines Questionnaire-Specific, BMQ-Specific, Medication Applied and Stustained Over Time, MAINTAIN, heart medication, adherance

mild stroke, acute ischemic stroke, IV thrombolysis, intravenous tissue plasminogen activator, t-PA, National Institutes of Health Stroke Scale, NIHSS, modified Rankin scale, mRS, symptomatic hemorrhagemild stroke, acute ischemic stroke, IV thrombolysis, intravenous tissue plasminogen activator, t-PA, National Institutes of Health Stroke Scale, NIHSS, modified Rankin scale, mRS, symptomatic hemorrhage

mild stroke, acute ischemic stroke, IV thrombolysis, intravenous tissue plasminogen activator, t-PA, National Institutes of Health Stroke Scale, NIHSS, modified Rankin scale, mRS, symptomatic hemorrhagemild stroke, acute ischemic stroke, IV thrombolysis, intravenous tissue plasminogen activator, t-PA, National Institutes of Health Stroke Scale, NIHSS, modified Rankin scale, mRS, symptomatic hemorrhage

mild stroke, acute ischemic stroke, IV thrombolysis, intravenous tissue plasminogen activator, t-PA, National Institutes of Health Stroke Scale, NIHSS, modified Rankin scale, mRS, symptomatic hemorrhagemild stroke, acute ischemic stroke, IV thrombolysis, intravenous tissue plasminogen activator, t-PA, National Institutes of Health Stroke Scale, NIHSS, modified Rankin scale, mRS, symptomatic hemorrhage

burning mouth syndrome, BMS, oral symptoms, dry mouth, impaired taste, menopause, parafunctional habit, topical lubricant, corticosteroidburning mouth syndrome, BMS, oral symptoms, dry mouth, impaired taste, menopause, parafunctional habit, topical lubricant, corticosteroid

burning mouth syndrome, BMS, oral symptoms, dry mouth, impaired taste, menopause, parafunctional habit, topical lubricant, corticosteroidburning mouth syndrome, BMS, oral symptoms, dry mouth, impaired taste, menopause, parafunctional habit, topical lubricant, corticosteroid

burning mouth syndrome, BMS, oral symptoms, dry mouth, impaired taste, menopause, parafunctional habit, topical lubricant, corticosteroidburning mouth syndrome, BMS, oral symptoms, dry mouth, impaired taste, menopause, parafunctional habit, topical lubricant, corticosteroid

african american, metastatic prostate cancer, androgen deprivation therapy, ADT, orchiectomy, luteinizing hormone-releasing hormone antagonists, Cancer, Endocrinology, Urologyafrican american, metastatic prostate cancer, androgen deprivation therapy, ADT, orchiectomy, luteinizing hormone-releasing hormone antagonists, Cancer, Endocrinology, Urology

african american, metastatic prostate cancer, androgen deprivation therapy, ADT, orchiectomy, luteinizing hormone-releasing hormone antagonists, Cancer, Endocrinology, Urologyafrican american, metastatic prostate cancer, androgen deprivation therapy, ADT, orchiectomy, luteinizing hormone-releasing hormone antagonists, Cancer, Endocrinology, Urology

african american, metastatic prostate cancer, androgen deprivation therapy, ADT, orchiectomy, luteinizing hormone-releasing hormone antagonists, Cancer, Endocrinology, Urologyafrican american, metastatic prostate cancer, androgen deprivation therapy, ADT, orchiectomy, luteinizing hormone-releasing hormone antagonists, Cancer, Endocrinology, Urology

opioid, cancer pain, palliative medicine, temporal pain patterns, pain management

opioid, cancer pain, palliative medicine, temporal pain patterns, pain management

opioid, cancer pain, palliative medicine, temporal pain patterns, pain management

antidepressant, type 2 diabetes, pharmacotherapy, bupropion, sertraline, Diabetes, Pharmacology, Endocrinologyantidepressant, type 2 diabetes, pharmacotherapy, bupropion, sertraline, Diabetes, Pharmacology, Endocrinology

antidepressant, type 2 diabetes, pharmacotherapy, bupropion, sertraline, Diabetes, Pharmacology, Endocrinologyantidepressant, type 2 diabetes, pharmacotherapy, bupropion, sertraline, Diabetes, Pharmacology, Endocrinology

antidepressant, type 2 diabetes, pharmacotherapy, bupropion, sertraline, Diabetes, Pharmacology, Endocrinologyantidepressant, type 2 diabetes, pharmacotherapy, bupropion, sertraline, Diabetes, Pharmacology, Endocrinology

dobutamine, arterial pulse transmission, systolic blood pressure, SBP, surrogate, cuff pressure, dobutamine infusion, cuff oscillometer, SphygmoCor, Pharmacology, Cardiovascular Diseasedobutamine, arterial pulse transmission, systolic blood pressure, SBP, surrogate, cuff pressure, dobutamine infusion, cuff oscillometer, SphygmoCor, Pharmacology, Cardiovascular Disease

dobutamine, arterial pulse transmission, systolic blood pressure, SBP, surrogate, cuff pressure, dobutamine infusion, cuff oscillometer, SphygmoCor, Pharmacology, Cardiovascular Diseasedobutamine, arterial pulse transmission, systolic blood pressure, SBP, surrogate, cuff pressure, dobutamine infusion, cuff oscillometer, SphygmoCor, Pharmacology, Cardiovascular Disease

dobutamine, arterial pulse transmission, systolic blood pressure, SBP, surrogate, cuff pressure, dobutamine infusion, cuff oscillometer, SphygmoCor, Pharmacology, Cardiovascular Diseasedobutamine, arterial pulse transmission, systolic blood pressure, SBP, surrogate, cuff pressure, dobutamine infusion, cuff oscillometer, SphygmoCor, Pharmacology, Cardiovascular Disease